Literature DB >> 20974297

Pseudophosphorylation of tau protein directly modulates its aggregation kinetics.

Edward Chang1, Sohee Kim, Kelsey N Schafer, Jeff Kuret.   

Abstract

Hyperphosphorylation of tau protein is associated with neurofibrillary lesion formation in Alzheimer's disease and other tauopathic neurodegenerative diseases. It fosters lesion formation by increasing the concentration of free tau available for aggregation and by directly modulating the tau aggregation reaction. To clarify how negative charge incorporation into tau directly affects aggregation behavior, the fibrillization of pseudophosphorylation mutant T212E prepared in a full-length four-repeat tau background was examined in vitro as a function of time and submicromolar tau concentrations using electron microscopy assay methods. Kinetic constants for nucleation and extension phases of aggregation were then estimated by direct measurement and mathematical simulation. Kinetic analysis revealed that pseudophosphorylation increased tau aggregation rate by increasing the rate of filament nucleation. In addition, it increased aggregation propensity by stabilizing mature filaments against disaggregation. The data suggest that incorporation of negative charge into the T212 site can directly promote tau filament formation at multiple steps in the aggregation pathway.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974297      PMCID: PMC3018534          DOI: 10.1016/j.bbapap.2010.10.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  57 in total

1.  Structural analysis of Pick's disease-derived and in vitro-assembled tau filaments.

Authors:  M E King; N Ghoshal; J S Wall; L I Binder; H Ksiezak-Reding
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Promotion of hyperphosphorylation by frontotemporal dementia tau mutations.

Authors:  Alejandra del C Alonso; Anna Mederlyova; Michal Novak; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Biol Chem       Date:  2004-06-09       Impact factor: 5.157

3.  Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.

Authors:  R Hoffmann; V M Lee; S Leight; I Varga; L Otvos
Journal:  Biochemistry       Date:  1997-07-01       Impact factor: 3.162

4.  Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants.

Authors:  Erin E Congdon; Sohee Kim; Jonathan Bonchak; Tanakorn Songrug; Anastasios Matzavinos; Jeff Kuret
Journal:  J Biol Chem       Date:  2008-03-21       Impact factor: 5.157

5.  A nucleated assembly mechanism of Alzheimer paired helical filaments.

Authors:  P Friedhoff; M von Bergen; E M Mandelkow; P Davies; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

6.  The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology.

Authors:  G Carmel; E M Mager; L I Binder; J Kuret
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

7.  The regulatory Ser262 of microtubule-associated protein tau is phosphorylated by phosphorylase kinase.

Authors:  H K Paudel
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

8.  New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.

Authors:  D P Hanger; J C Betts; T L Loviny; W P Blackstock; B H Anderton
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372

9.  Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments.

Authors:  H Ksiezak-Reding; W K Liu; S H Yen
Journal:  Brain Res       Date:  1992-12-04       Impact factor: 3.252

10.  Effects of the neuronal phosphoprotein synapsin I on actin polymerization. II. Analytical interpretation of kinetic curves.

Authors:  R Fesce; F Benfenati; P Greengard; F Valtorta
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

View more
  13 in total

1.  Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.

Authors:  Gayathri Ramachandran; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Tau isoform composition influences rate and extent of filament formation.

Authors:  Qi Zhong; Erin E Congdon; Haikady N Nagaraja; Jeff Kuret
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

Review 3.  The structure and phase of tau: from monomer to amyloid filament.

Authors:  Yifan Zeng; Jing Yang; Bailing Zhang; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Mol Life Sci       Date:  2020-10-19       Impact factor: 9.261

Review 4.  Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.

Authors:  Jennifer N Rauch; Steven H Olson; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

5.  Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach.

Authors:  Stefani N Thomas; Kristen E Funk; Yunhu Wan; Zhongping Liao; Peter Davies; Jeff Kuret; Austin J Yang
Journal:  Acta Neuropathol       Date:  2011-10-28       Impact factor: 17.088

Review 6.  The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.

Authors:  Haiqiong Ye; Yue Han; Ping Li; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2022-03-24       Impact factor: 2.866

7.  Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention.

Authors:  Aaron Carman; Sarah Kishinevsky; John Koren; Wenjie Lou; Gabriela Chiosis
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-04

Review 8.  "Don't Phos Over Tau": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies.

Authors:  Yuxing Xia; Stefan Prokop; Benoit I Giasson
Journal:  Mol Neurodegener       Date:  2021-06-05       Impact factor: 14.195

9.  PrP charge structure encodes interdomain interactions.

Authors:  Javier Martínez; Rosa Sánchez; Milagros Castellanos; Natallia Makarava; Adriano Aguzzi; Ilia V Baskakov; María Gasset
Journal:  Sci Rep       Date:  2015-09-01       Impact factor: 4.379

10.  Interplay of pathogenic forms of human tau with different autophagic pathways.

Authors:  Benjamin Caballero; Yipeng Wang; Antonio Diaz; Inmaculada Tasset; Yves Robert Juste; Barbara Stiller; Eva-Maria Mandelkow; Eckhard Mandelkow; Ana Maria Cuervo
Journal:  Aging Cell       Date:  2017-10-12       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.